Table 1.
Characteristics | Values |
---|---|
Age, years, mean (s.d.) | 60 (12) |
Female, n (%) | 68 (80) |
Currently smoking, n (%) | 10 (12) |
Disease duration, months, median (IQR) | 72 (33, 132) |
RP duration, months, median (IQR) | 132 (60, 240) |
lcSSc, n (%) | 51 (60) |
Digital ulcers (current), n (%) | 6 (7) |
Pitting scars (current), n (%) | 36 (42) |
SSc pattern on NC, n (%) | 66 (78) |
Early SSc pattern, n | 10 |
Active SSc pattern, n | 27 |
Late SSc pattern, n | 29 |
Vasoactive medication, n (%) | 57 (67) |
Prior RCS scorea (1–10), mean (s.d.) | 6.4 (1.6) |
Vasoactive medication included the use of calcium channel blockers, endotheline-1 antagonists and PDE5 inhibitors.
Mean RCS during the 2 weeks before the start of the trial (without wearing gloves).
NC: nailfold capillaroscopy.